NCT06317714 Long-term Follow-up and Quality of Life of Patients Treated With Anticancer Drugs
| NCT ID | NCT06317714 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Institut Rafael |
| Condition | Oncology |
| Study Type | OBSERVATIONAL |
| Enrollment | 300 participants |
| Start Date | 2024-03-08 |
| Primary Completion | 2027-03-08 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.
This trial targets 300 participants in total. It began in 2024-03-08 with a primary completion date of 2027-03-08.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
Currently, aspects related to the effects of anticancer treatments and the quality of life of patients and their needs are still poorly documented at the Rafael Institute. Thus this study will meet a dual objective: (1) the establishment of a registry to collect data on the safety and effectiveness of innovative and expensive anticancer drugs when administered in real life and (2) a measurement quantitative quality of life of patients treated with these drugs.
Eligibility Criteria
Inclusion Criteria: * Age equal to or greater than 18 years (adult) * Patients treated with an anticancer drug included in the list of innovative/expensive therapies (protocol appendix) * Patients benefiting from non-pharmacological treatment at the Rafael Institute * Who understands the French language Exclusion Criteria: * \< 18 years old * Patient deprived of liberty, under guardianship or unable to give consent
Contact & Investigator
Frequently Asked Questions
Who can join the NCT06317714 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, studying Oncology. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT06317714 currently recruiting?
Yes, NCT06317714 is actively recruiting participants. Contact the research team at alain.toledano@horg.fr for enrollment information.
Where is the NCT06317714 trial being conducted?
This trial is being conducted at Levallois-Perret, France.
Who is sponsoring the NCT06317714 clinical trial?
NCT06317714 is sponsored by Institut Rafael. The trial plans to enroll 300 participants.